Leerink Partners Downgrades Replimune Group (REPL) to Market Perform

April 13, 2026 6:08 AM

Leerink Partners analyst Jonathan Chang downgraded Replimune Group (NASDAQ: REPL) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found